Arzneiwerk AG VIDA (HAM:TLIK) GF Score: 40/100 (As of Aug. 31, 2026) — 18% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:TLIK Arzneiwerk AG VIDA HAM:TLIK
40 GF Score
Price €0.20
! 7 Warning Signs
View Full Analysis

What is Arzneiwerk AG VIDA GF Score?

Arzneiwerk AG VIDA HAM:TLIK 40 GF Score is 40 as of Aug. 31, 2026, which is 18% above its 10-year median of 34.00. GuruFocus rates HAM:TLIK with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

Arzneiwerk AG VIDA has the GF Score of 40, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 2/10
3. Growth Rank : 1/10
4. GF Value Rank : 2/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Arzneiwerk AG VIDA might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Arzneiwerk AG VIDA  (HAM:TLIK) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Arzneiwerk AG VIDA GF Score Related Terms

HAM:TLIK vs MCK, COR, CAH: GF Score Comparison

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arzneiwerk AG VIDA GF Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's GF Score distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's GF Score falls into.


HAM:TLIK
40GF Score
Arzneiwerk AG VIDA HAM:TLIK
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 40 mean?
Arzneiwerk AG VIDA (HAM:TLIK) has a GF Score of 40 as of Aug. 31, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Arzneiwerk AG VIDA and its competitors. This is 18% above median its historical median of 34.00. Over the past decade, Arzneiwerk AG VIDA's GF Score has ranged from 15.00 to 58.00.
Is Arzneiwerk AG VIDA's GF Score too high?
Arzneiwerk AG VIDA's current GF Score of 40 is 18% above median its 10-year median of 34.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 58.00. Overall, Arzneiwerk AG VIDA has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Arzneiwerk AG VIDA's GF Score compare to MCK and COR?
Arzneiwerk AG VIDA's GF Score of 40 can be compared against companies in the Medical Distribution industry. Historically, Arzneiwerk AG VIDA's own GF Score has ranged from 15.00 to 58.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Arzneiwerk AG VIDA and its competitors. Arzneiwerk AG VIDA's current GF Score is 40, which is 18% above median its own 10-year median of 34.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arzneiwerk AG VIDA stock overvalued right now?
Arzneiwerk AG VIDA (HAM:TLIK) has a current GF Score of 40. The current GF Score is 40, which is 18% above median its 10-year median of 34.00. Arzneiwerk AG VIDA's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Arzneiwerk AG VIDA (HAM:TLIK), the current GF Score is 40 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arzneiwerk AG VIDA Business Description

Other Exchanges TLIK:Germany
Address Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
40GF Score

Get the complete analysis for HAM:TLIK

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price